AspenBio Pharma (APPY) says a U.S. District Court APPY) says a U.S. District Court has dismissed...
AspenBio Pharma (APPY) says a U.S. District Court has dismissed both a class action lawsuit against the company and certain of its former or current officers and directors, and the Mark Chipman lawsuit filed against against it. Shares +7.2% AH.
From other sites
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs